Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07618104

Pornography Abstinence and Nocturnal Erections in Adult Men

The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.

Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

About this study

This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.

During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.

Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.

Study Design

Study Type: Observational

Study Design: Single-arm, within-participant comparison

Time Perspective: Prospective

Masking: None (Open Label)

Primary Purpose: Health outcomes assessment / signal detection

Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult males of legal age of consent
  • Willingness to attempt pornography abstinence
  • Ability to use a wearable device during sleep
  • Ability to complete electronic surveys
  • Willingness to purchase the study device

Exclusion criteria

  • Have a history of significant sexual dysfunction requiring active medical treatment
  • Have current or uncontrolled mental health disorders
  • Have a history of addictive behaviors that may be exacerbated by abstinence
  • Are undergoing hormonal therapy or treatment affecting sexual function
  • Are experiencing unstable interpersonal or relationship stressors
  • Have significant concerns about privacy related to sexual health data
  • Have cultural or religious considerations that could cause distress

Treatment and study plan

Pornography Abstinence

Behavioral

Participants will attempt to abstain from all pornography use for 30 consecutive days. Any deviations from abstinence are self-reported and logged for contextual analysis.

Primary outcomes

  1. Change in Nocturnal Penile Tumescence

    Time frame: Baseline Day to Day 38

    Measure: Adam Sensor - Nocturnal Erection Tracking

    Description:

    Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night

Secondary outcomes

  1. Change in Erectile Function

    Time frame: Baseline to Day 38 after intervention

    Measure: International Index of Erectile Function (IIEF-15)

    Scale Range: 5-75 (higher scores indicate better erectile and sexual function)

    Description:

    Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction.

  2. Change in Sexual Desire

    Time frame: Baseline to Day 38 after intervention

    Measure: Sexual Desire Inventory-2 (SDI-2)

    Scale Range: 0-112 (higher scores indicate greater sexual desire)

    Description:

    Measures both dyadic and solitary sexual desire.

  3. Change in Pornography Consumption Patterns

    Time frame: Baseline to Day 38 after intervention

    Measure: Weekly Pornography Consumption Survey (custom self-report)

    Scale: Frequency and duration categories (ordinal)

    Description:

    Tracks self-reported pornography use and abstinence adherence.

  4. Change in Mood, Energy, and Emotional Well-Being

    Time frame: Baseline to Day 38 after intervention

    Measure: Weekly Self-Assessment Check-In (custom)

    Scale: 1-10 Likert-type scales (higher scores indicate more favorable states)

    Description:

    Assesses perceived mood, mental clarity, energy level, and emotional resilience.

Study contacts

Contact information is provided by the study sponsor or research team.

Matthew Amsden

CONTACT

[email protected]

(646) 679-2479

Sponsors and collaborators

Lead sponsor

Efforia, Inc

Industry

Registry information

Official study title

A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 1, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.